High
CMS
CMS Finalizes Most-Favored Nation Pricing Model for Medicare Part B
The finalized model applies international price comparisons to Medicare Part B drugs, potentially reshaping reimbursement for oncology and specialty therapies. The Centers for Medicare & Medicaid Services (CMS) has finalized the Most Favored Nation (MFN) Model, which aims to align Medicare Part B...
Create a free account to read this complete brief and one more from every weekly edition. No card required.
Create a free accountSources — verify every claim